Distinct temporal trajectories and risk factors for Post-acute sequelae of SARS-CoV-2 infection.
Publication Title
Front Med (Lausanne)
Document Type
Article
Publication Date
1-1-2023
Keywords
COVID-19; PASC; SARS-CoV-2; long COVID; symptom clusters.; california; torrance; plcmmc; covid-19
Abstract
BACKGROUND: The understanding of Post-acute sequelae of SARS-CoV-2 infection (PASC) can be improved by longitudinal assessment of symptoms encompassing the acute illness period. To gain insight into the various disease trajectories of PASC, we assessed symptom evolution and clinical factors associated with the development of PASC over 3 months, starting with the acute illness period.
METHODS: We conducted a prospective cohort study to identify parameters associated with PASC. We performed cluster and case control analyses of clinical data, including symptomatology collected over 3 months following infection.
RESULTS: We identified three phenotypic clusters associated with PASC that could be characterized as remittent, persistent, or incident based on the 3-month change in symptom number compared to study entry: remittent (median; min, max: -4; -17, 3), persistent (-2; -14, 7), or incident (4.5; -5, 17) (
CONCLUSION: An incident disease phenotype characterized by symptoms that were absent during acute illness and the observed association with high dose steroids during acute illness have potential critical implications for preventing PASC.
Specialty/Research Institute
Infectious Diseases
Specialty/Research Institute
Internal Medicine
